4.7 Review

Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives

Journal

JOURNAL OF CLINICAL ONCOLOGY
Volume 36, Issue 2, Pages 160-+

Publisher

AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2017.75.3467

Keywords

-

Categories

Funding

  1. PharmaMar
  2. GlaxoSmithKline
  3. Novartis
  4. MSD
  5. AstraZeneca
  6. NATIONAL CANCER INSTITUTE [ZIASC010354] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Undifferentiated pleomorphic sarcomas, myxofibrosarcomas, and malignant peripheral nerve sheath tumors are characterized by complex genomic characteristics and aggressive clinical behavior. Recent advances in the understanding of the pathogenesis of these tumors may allow for the development of more-effective innovative therapeutic strategies, including immunotherapies. This review describes the current knowledge of the epidemiology, clinical presentation, treatment, and pathogenesis of these tumors and highlights ongoing and future research. (c) 2017 by American Society of Clinical Oncology

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available